MEDICOX Statistics

Total Valuation

MEDICOX has a market cap or net worth of KRW 8.62 billion. The enterprise value is 21.31 billion.

Market Cap	8.62B
Enterprise Value	21.31B

Important Dates

The next estimated earnings date is Thursday, May 15, 2025.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

MEDICOX has 82.87 million shares outstanding. The number of shares has increased by 98.62% in one year.

Current Share Class	82.87M
Shares Outstanding	82.87M
Shares Change (YoY)	+98.62%
Shares Change (QoQ)	+0.93%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	48.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.28
PB Ratio	0.16
P/TBV Ratio	0.16
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.99
EV / Sales	0.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.04

Financial Position

The company has a current ratio of 0.56, with a Debt / Equity ratio of 0.36.

Current Ratio	0.56
Quick Ratio	0.34
Debt / Equity	0.36
Debt / EBITDA	n/a
Debt / FCF	-2.67
Interest Coverage	-4.67

Financial Efficiency

Return on equity (ROE) is -37.02% and return on invested capital (ROIC) is -8.93%.

Return on Equity (ROE)	-37.02%
Return on Assets (ROA)	-7.53%
Return on Invested Capital (ROIC)	-8.93%
Return on Capital Employed (ROCE)	-18.73%
Revenue Per Employee	377.92M
Profits Per Employee	-264.63M
Employee Count	81
Asset Turnover	0.34
Inventory Turnover	20.26

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -82.96% in the last 52 weeks. The beta is -0.36, so MEDICOX's price volatility has been lower than the market average.

Beta (5Y)	-0.36
52-Week Price Change	-82.96%
50-Day Moving Average	242.68
200-Day Moving Average	367.52
Relative Strength Index (RSI)	21.28
Average Volume (20 Days)	6,821,597

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MEDICOX had revenue of KRW 30.61 billion and -21.43 billion in losses. Loss per share was -372.54.

Revenue	30.61B
Gross Profit	1.98B
Operating Income	-10.79B
Pretax Income	-21.50B
Net Income	-21.43B
EBITDA	-8.69B
EBIT	-10.79B
Loss Per Share	-372.54

Full Income Statement

Balance Sheet

The company has 6.03 billion in cash and 18.72 billion in debt, giving a net cash position of -12.69 billion or -153.11 per share.

Cash & Cash Equivalents	6.03B
Total Debt	18.72B
Net Cash	-12.69B
Net Cash Per Share	-153.11
Equity (Book Value)	52.45B
Book Value Per Share	761.50
Working Capital	-10.55B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.63 billion and capital expenditures -366.46 million, giving a free cash flow of -7.00 billion.

Operating Cash Flow	-6.63B
Capital Expenditures	-366.46M
Free Cash Flow	-7.00B
FCF Per Share	-84.47

Full Cash Flow Statement

Margins

Gross margin is 6.48%, with operating and profit margins of -35.25% and -70.02%.

Gross Margin	6.48%
Operating Margin	-35.25%
Pretax Margin	-70.23%
Profit Margin	-70.02%
EBITDA Margin	-28.38%
EBIT Margin	-35.25%
FCF Margin	n/a

Dividends & Yields

MEDICOX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-98.62%
Shareholder Yield	-98.62%
Earnings Yield	-248.71%
FCF Yield	-81.22%

Stock Splits

The last stock split was on November 16, 2022. It was a forward split with a ratio of 2.

Last Split Date	Nov 16, 2022
Split Type	Forward
Split Ratio	2

Scores

MEDICOX has an Altman Z-Score of -1.19. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.19
Piotroski F-Score	n/a